Definition
- Essential:
- Biphasic histomorphology with a AND
- Neurocytic component (rosettes and/ or perivascular pseudorosettes)
- Glial component (resembling pilocytic astrocytoma)
- Uniform neurocytes forming rosettes and/or perivascular pseudorosettes associated with synaptophysm expression AND (for unresolved lesions)
- Small biopsies showing only one tumour component (neurocytic or glial) and a methylation profile of rosette-forming glioneuronal tumour
- Desirable:
- FGFR1 mutation with co-occurring PIK3CA and/or NF1 mutation
Grading
- WHO Grade 1
Number
- Rare not much data on it
Clinical features
- Obstructive hydrocephalus
- H/A
- Cerebellar signs
- Ataxia
Localisation
- Midline
- 4th ventricle and/or aqueduct
- Can extend to involve adjacent brain stem, cerebellar vermis, pineal gland, or thalamus
- Other sites rare (20%)
- Pineal region
- Optic chiasm
- Spinal cord
- Septum pellucidum
Origin
- Brain tissue surrounding the ventricular system
Radiology
General
- Variable solid-cystic components:
- Entirely solid: 40%
- Mixed solid and cystic: 35%
- Entirely cystic: 25%
CT
- On CT these tumours are of variable appearance reflecting the solid and cystic components. Calcification is seen in approximately a quarter of cases.
MRI
- As expected, the cystic components demonstrate high T2 signal, whereas the solid components demonstrate variable gadolinium enhancement.
Images
Histopathology
Macroscopic
- Cystic and solid component
Microscopic
- Biphasic neurocytic and glial architecture
- Uniform neurocytes forming rosettes and/ or perivascular pseudorosettes
- Astrocytic in nature and resembling pilocytic astrocytoma.
- Proliferation index (Ki-67) is usually low, <3%
Immunophenotype
- The glial component demonstrates:
- GFAP: positive
- S100: positive
- The neurocytic component demonstrates:
- MAP2: positive
- Neurone-specific enolase: positive
- Synaptophysin: positive in the centre of the neurocytic rosettes
Genetic profile
- Some association with NF1 but not part of diagnostic criteria
- Missense mutation in exon 20 of PIK3CA
- FGFR1 mutation
Management
- Surgery
- Difficult because of
- Tumour location
- Adherence and/ or infiltration of adjacent structures
- Resulting in relatively high rate of new postoperative deficits.
- Zhang et al., 2013
- Failed to show the superiority of a gross total over a subtotal resection
Prognosis
- Good prognosis but most patient suffer complication of surgery
- Metastatic dissemination has been seen in as many as 7%
Differential diagnosis
- Pilocytic astrocytoma (most commonly mistaken with)
- Pilocystic astrocytoma has BUT Rosette-forming glioneuronal tumour do not
- KIAA1549-BRAF fusions
- BRAF V600E
- Histologically the glial component very similar
- Gangliogliomas and gangliocytomas
- Pleomorphic xanthoastrocytoma (almost always hemispheric)
- Papillary glioneuronal tumour (usually hemispheric)